iHuman (IH) director discloses multiple option grants on Form 3

Rhea-AI Filing Summary

iHuman Inc. director Wendy W. Hayes filed an initial Form 3 reporting option holdings tied to Class A ordinary shares. She holds options covering 53,000 underlying shares at an exercise price of $0.0500 per share expiring on November 30, 2030, and another grant covering 53,000 underlying shares at the same exercise price expiring on December 15, 2032. The earlier grant vested in three annual tranches from October 8, 2021 to October 8, 2023, while the later grant vests in four equal annual installments after its December 15, 2022 grant date. This filing records existing derivative positions and does not show any new purchases or sales.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Hayes Wendy W.

Role Director

Type	Security	Shares	Price	Value
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Options — 53,000 shares (Direct)

Footnotes (1)

1. These options were granted on November 30, 2020 and vested over a three-year period, with 33.33% of the options vesting on October 8, 2021, 33.33% on October 8, 2022, and the remaining 33.34% on October 8, 2023. These options were granted on December 15, 2022 and vest in equal installments over a four-year period, with 25% of the options vest on each anniversary after the grant date.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hayes Wendy W.

(Last) (First) (Middle)

12271 MONUMENT HILL AVE

(Street)

LAS VEGAS NEVADA 89138

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
iHuman Inc. [ IH ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	(1)	11/30/2030	Class A ordinary shares	53,000	$0.05	D
Options	(2)	12/15/2032	Class A ordinary shares	53,000	$0.05	D

Explanation of Responses:

1. These options were granted on November 30, 2020 and vested over a three-year period, with 33.33% of the options vesting on October 8, 2021, 33.33% on October 8, 2022, and the remaining 33.34% on October 8, 2023.

2. These options were granted on December 15, 2022 and vest in equal installments over a four-year period, with 25% of the options vest on each anniversary after the grant date.

	/s/ Wendy Hayes	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)